Riferimento farmaci
Pitavastatin
Pitavastatin is a medicine in the class cardiovascular. It is used for dyslipidemia.
- Classe del farmaco: Cardiovascular
- Indicato per: dyslipidemia
Ultimo aggiornamento
Per operatori sanitari — solo a scopo di riferimento. Questa pagina è una sintesi breve, non è un parere medico e non sostituisce il RCP ufficiale né il giudizio clinico. Verificare sempre prima di prescrivere o dispensare.
Il contenuto clinico di questa pagina è disponibile solo in inglese.
In breve
- Classe del farmaco
- Cardiovascular
- Forme farmaceutiche comuni
- compressa
- Dosaggi comuni
- 2 mg, 4 mg, 1 mg
- Interazioni note
- 82 (Controindicata: 2 · Maggiore: 11 · Moderata: 45 · Minore: 24)
- Nomi commerciali
- 24
- Paesi e mercati
- 4
Per cosa si usa
Come agisce
HMG-CoA reductase inhibitor, inhibits rate-limiting step in cholesterol biosynthesis by competitively inhibiting HMG-CoA reductase
Dose abituale nell'adulto (sintesi del foglio illustrativo)
Hyperlipidemia: Recommended starting dose: 2 mg PO qDay May increase to 4 mg PO qDay if necessary
Come si assume di solito
Statins are taken by mouth once a day, long term, with blood tests to check the response and liver function.
Gravidanza e allattamento
- Gravidanza
- Unsafe EU labels contraindicate it in pregnancy and in women not using contraception (reduced fetal cholesterol synthesis); stop 1 month before conceiving. US label (2026) no longer does: stop when pregnancy is recognised unless the need is compelling; statin data show no rise in birth defects.
- Allattamento
- Unsafe Not known if it passes into human milk; it passes into rat milk and is 99% protein bound. EU label: contraindicated; US label: not recommended (possible effects on infant lipid metabolism). LactMed: consensus is not to use it; some experts consider pravastatin or rosuvastatin lower risk. Avoid.
Effetti indesiderati segnalati
- Diarrhea
- Constipation
- Back pain
- Myalgia
- Pain in extremity
Chi deve prestare attenzione
- Increased serum transaminases reported; typically, elevations are transient and either resolved or improved on continued therapy or after briefly interrupting therapy
- Myopathy risk factors include: age ≥65 yr, uncontrolled hypothyroidism, renal impairment, coadministration of drugs that decrease statin clearance or add to myopathy risk
- Contraindicated: Coadministration with cyclosporine
Unexplained muscle pain, tenderness or weakness while taking a statin should be reported promptly. Statins are not used in pregnancy, and some other medicines raise their levels and risk.
Informare il farmacista o il medico di gravidanza o allattamento, malattie renali o epatiche, allergie e di ogni altro farmaco o integratore assunto.
Interazioni principali (82)
- Cyclosporin + Pitavastatin Contraindicated
- Cyclosporine + Pitavastatin Contraindicated
- Erythromycin + Pitavastatin Major
- Erythromycin base + Pitavastatin Major
- Erythromycin ethylsuccinate + Pitavastatin Major
- Erythromycin lactobionate + Pitavastatin Major
- Erythromycin stearate + Pitavastatin Major
- Gemfibrozil + Pitavastatin Major
- Glecaprevir / pibrentasvir + Pitavastatin Major
- Letermovir + Pitavastatin Major
Per gli utenti Pro+
Sblocca la pagina completa
Crei un account e avvii una prova di Pro+ per aprire la monografia completa di Pitavastatin: dosi, gravidanza e allattamento, effetti indesiderati, avvertenze e tutte le interazioni.
- Dosing by age, kidney and liver function, and further dose lines
- Paediatric dosing
- Patient counselling points
- Food interactions
Provi Pro+ gratis per 14 giorni sul web. Nessuna carta.
Altri farmaci della stessa classe
Domande frequenti
What is Pitavastatin used for?
Pitavastatin is a medicine in the class cardiovascular. It is used for Dyslipidemia, Hypercholesterolemia.
What side effects have been reported with Pitavastatin?
Diarrhea, Constipation, Back pain, Myalgia, Pain in extremity.
Can Pitavastatin be taken in pregnancy or while breastfeeding?
Pregnancy: Unsafe. EU labels contraindicate it in pregnancy and in women not using contraception (reduced fetal cholesterol synthesis); stop 1 month before conceiving. US label (2026) no longer does: stop when pregnancy is recognised unless the need is compelling; statin data show no rise in birth defects. Breastfeeding: Unsafe. Not known if it passes into human milk; it passes into rat milk and is 99% protein bound. EU label: contraindicated; US label: not recommended (possible effects on infant lipid metabolism). LactMed: consensus is not to use it; some experts consider pravastatin or rosuvastatin lower risk. Avoid.
What does Pitavastatin interact with?
MediHelp lists 82 known interactions for Pitavastatin. Contraindicated: 2 · Major: 11 · Moderate: 45 · Minor: 24. The most serious include Cyclosporin, Cyclosporine, Erythromycin.
Monografie complete, posologie e verifica delle interazioni nell'app MediHelp
Apra il riferimento completo, verifichi le interazioni tra più farmaci e usi gli strumenti di posologia nell'app MediHelp.